Atlas Trials

Subject Satisfaction With AbobutulinumtoxinA Treatment

Clinical trial NCT03687736 · COMPLETED

Trial details

NCT number
NCT03687736
Sponsor
Galderma R&D
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Glabellar Frown Lines
Start date
2018-10-02
Primary completion
2019-11-07
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.